Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,938,820
+$184,467 QoQ
Shares Held
15,509
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1,782
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIERRA SUMMIT ADVISORS LLC holds $37,799,152 across 6 Drug Manufacturers - General names. JNJ ranks #3 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
19,926 | $23,899,844 | |
| 2 | ABBV |
AbbVie Inc.
|
17,459 | $4,393,382 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
15,509 | $3,938,820 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,917 | $2,816,334 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,647 | $1,420,160 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,532 | $1,330,612 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,938,820 | 15,509 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,754,353 | 15,359 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,937,241 | 14,193 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,584,198 | 13,937 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,102,603 | 13,765 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,331,710 | 14,060 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,014,122 | 13,927 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,822,364 | 11,245 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,343,941 | 9,195 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,350,784 | 8,539 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,362,540 | 8,693 | Shares | Sole | 2024-02-22 | |
| No filing history on record for this holder in this stock. | ||||||